UBS AM’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Other funds holding STRO
KCM
UBS AM's STRO Position: Q3 2026 in Review
UBS AM opened a new position in Sutro Biopharma (STRO) in Q3 2026: 1,442 shares worth $23.2K. The stake represents ﹤0.01% of the portfolio and ranks #3608 among its holdings. This is a return to the name: UBS AM previously reported a position in STRO as recently as Q1 2022.
UBS AM first reported a position in STRO in Q1 2022 and has held it in 2 quarters since. The position peaked at $165K in Q1 2022. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.
- UBS AM held 1,442 shares of Sutro Biopharma worth $23.2K as of Q3 2026.
- Sutro Biopharma was a new UBS AM position in Q3 2026.
- Sutro Biopharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3608 holding.
- UBS AM first reported a position in Sutro Biopharma in Q1 2022 and has held it in 2 quarters since.
- UBS AM's Sutro Biopharma position peaked at $165K in Q1 2022.
- 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.